-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

102.P1.33 102. Iron Homeostasis and Biology: Poster I

Symposia: Iron Homeostasis and Biology Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Vida Zhang, PhD*, Joseph Olivera, PhD*, Richard Coffey, PhD, Elizabeta Nemeth, PhD and Tomas Ganz, MD, PhD

Center for Iron Disorders, UCLA, Los Angeles, CA

Richa Sharma1*, S. Zebulon Vance1*, Ada Antypiuk1*, Deepa Manwani, MD2, Quentinn Pearce3*, James E. Cox, PhD3*, Xiuli An4, Karina Yazdanbakhsh, PhD5 and Francesca Vinchi, PhD6

1Iron Research Laboratory, Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY
2Division of Pediatric Hematology/Oncology, Department of Pediatrics, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY
3Biochemistry, University of Utah, Salt Lake City, UT
4Laboratory of Membrane Biology, New York Blood Center, New York
5Laboratory of Complement Biology, New York Blood Center, New York, NY
6Iron Research Laboratory, New York Blood Center, New York, NY

Wenbin An, MD1,2*, Srinivas Aluri3*, Maayan Levy, MS2*, Eitan Fibach, PhD4*, Xiaofan Zhu, MD5, Amit Verma, MD6 and Yelena Ginzburg, MD7

1Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Tianjin, China
2Icahn School of Medicine at Mount Sinai, New York
3Department of Oncology, Albert Einstein College of Medicine, Bronx, NY
4Hematology, Hadassah - Hebrew University Medical Center, Jerusalem, Israel, Jerusalem, ISR
5Department of Pediatric Blood Diseases Center, Institute of Hematology & Blood Diseases Hospital, Tianjin, China
6Department of Hematology and Medical Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
7Division of Hematology Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Eduard J. Van Beers, MD, PhD1*, Hanny Al-Samkari, MD2, Rachael F. Grace, MD3, Wilma Barcellini, MD4*, Andreas Glenthøj, MD, PhD5, Melissa Dibacco, MD6*, Penelope A. Kosinski, MS6*, Emily Xu, PhD6*, Vanessa Beynon, MD6*, Parija Patel, PharmD, MBA6*, John B. Porter, MD, FRCP, FRCPath7* and Kevin H.M. Kuo, MD, MSc, FRCPC8

1Benign Hematology Center, Van Creveldkliniek, University Medical Center Utrecht, University of Utrecht, Utrecht, Netherlands
2Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
3Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA
4Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
5Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
6Agios Pharmaceuticals, Inc., Cambridge, MA
7Haematology Department, University College London Hospitals, London, United Kingdom
8Division of Hematology, Department of Medicine, University of Toronto, Toronto, ON, Canada

Nermi Parrow, PhD1, Nisha George, PhD2*, Faris Ali, BS1, Nadia Wattad, MD3*, Amaliris Guerra, PhD4*, Yelena Ginzburg, MD5, Stefano Rivella, PhD6 and Robert E Fleming, MD7,8

1Pediatrics, Saint Louis University School of Medicine, Saint Louis, MO
2Saint Louis University School of Medicine, St Louis
3Saint Louis University School of Medicine, St Louis, MO
4Department of Pediatrics, Division of Hematology, The Children’s Hospital of Philadelphia, Philadelphia, PA
5Division of Hematology Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
6Department of Pediatrics, Division of Hematology, Children’s Hospital of Philadelphia, Philadelphia, PA
7Pediatrics, Saint Louis University School of Medicine, University City, MO
8Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University, St. Louis, MO

Annie Qiu, B.S.*, Lin Wang*, Flavia Dei Zotti, PhD*, Krystalyn E Hudson, PhD, Eldad A. Hod, MD and Francesca La Carpia, PhD*

Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY

Koya Ono, MD1,2*, Tohru Fujiwara, MD, PhD1,3, Hiroki Shima, PhD4*, Hironari Nishizawa, MD, PhD4*, Chie Suzuki, MS3*, Noriyuki Takahashi3*, Hiroki Kato, MD, PhD1*, Koichi Onodera, MD, PhD1*, Satoshi Ichikawa, MD, PhD1*, Noriko Fukuhara, MD, PhD5, Yasushi Onishi, MD, PhD1*, Hisayuki Yokoyama, MD, PhD1, Yukio Nakamura, MD, PhD6*, Kazuhiko Igarashi, MD, PhD4* and Hideo Harigae, MD, PhD1,3

1Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
2Division of Hematology, Sendai City Hospital, Sendai, Japan
3Laboratory Diagnostics, Tohoku University Hospital, Sendai, Japan
4Department of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan
5Department of Hematology, Tohoku University School of Medicine, Sendai, Japan
6Cell Engineering Division, RIKEN BioResource Research Center, Tsukuba, Japan

Amit R. Mehta, MD1, Myles Wolf, MD, MMsc2* and Heinz Zoller, MD3*

1Duke University - Duke Cancer Institute, Cary, NC
2Division of Nephrology, Duke University School of Medicine, Durham, NC
3Department of Medicine I, Gastroenterology, Hepatology and Endocrinology, Medical University of Innsbruck, Innsbruck, Austria

Andrew J Baldi, MBBS, FRACP, FRCPA1*, Sant-Rayn Pasricha, MD, PhD2,3,4, Aaron R Jex5*, M Imrul Hasan5,6*, Naomi Jones5*, Marilou Barrios7*, Sabine Braat, MSc5,8*, Jena Hamadani, PhD6*, Stephen Wilcox7*, Beverley-Ann Biggs9* and Rory Bowden7*

1Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Flemington, VIC, Australia
2Clinical Haematology, Royal Melbourne Hospital & Peter MacCallum Cancer Centre, Parkville, Australia
3Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia
4Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Fitzroy North, VIC, Australia
5Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
6International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
7Genomics Laboratory, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
8Methods and Implementation Support for Clinical and Health Research Hub, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia
9Doherty Institute of Infection and Immunity, University of Melbourne, Melbourne, Australia

Ling-Hsiang Chuang, PhD1*, Wentao Sun, MS2*, Yujie Sun, MD2* and Bing Han, MD/PhD3*

1Department of Epidemiology and Global Health, Umea University, Umea, Sweden
2Vifor Fresenius Kabi (Beijing) Pharmaceutical Consulting Co. Ltd, Beijing, China
3Beijing Union Medical College Hospital, Beijing, China

Vera Hoving1,2*, Albertine Donker2,3*, Enrikas Vainorius, MD4*, Harveen Dhillon Natarajan, PhD4*, Jenn Lachey, PhD4, Simon Cooper, MBBS4*, Dorine W. Swinkels, MD, PhD2,5,6* and Saskia Schols1,2*

1Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
2Radboud Expertise Center for Iron Disorders, Radboud University Medical Center, Nijmegen, Netherlands
3Department of Pediatrics, Máxima Medical Center, Veldhoven, Netherlands
4Keros Therapeutics, Lexington, MA
5Sanquin Blood Bank, Sanquin Diagnostics BV, Amsterdam, Netherlands
6Translational Metabolic Laboratory, Radboud University Medical Center, Nijmegen, Netherlands

*signifies non-member of ASH